Skip to main content

Table 2 Baseline characteristics of the cohorts

From: Comparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk

  All GEDAPS 2007 IDIME PERCEDIME2
n = 3,041 n = 1,774 n = 605 n = 662
Age, years, mean (SD)** 60.4 (9.7) 62.4 (9.0) 53.6 (9.7) 61.3 (8.6)
Gender, men, n (%)* 1638 (53.8) 929 (52.3) 328 (54.2) 384 (58.0)
Years since diabetes diagnosis, mean (SD)** 6.7 (5.5) 6.3 (5.1) 6.6 (6.2) 7.8 (5.8)
Afroamericans/Afrocaribbeans, n (%)** 187 (14.8)   170 (28.1) 17 (2.6)
Tobacco, n (%)** 435 (14.3) 317 (17.8) 4 (0.6) 116 (17.5)
BMI, kg/m2, mean (SD) 30.5 (5.1) 30.5 (5.1) 29.9 (5.8) 30.5 (5.3)
Waist circumference, cm, mean (SD)* 100.9 (15.7)   102.4 (13.2) 99.7 (7.3)
Pulse pressure, mmHg, mean (SD)** 56.9 (13.1) 58.2 (12.9) 55.2 (15.1) 55.6 (11.4)
Glycated haemoglobin, %, mean (SD)** 7.1 (1.6) 6.8 (1.5) 7.6 (1.9) 7.3 (1.3)
HDL, mg/dL, mean (SD)** 48.8 (13.3) 49.8 (13.2) 47.4 (13.9) 47.9 (12.7)
Non-HDL cholesterol** 146.9 (38.3) 148.3 (37.1) 150.9 (43.7) 140.2 (35.1)
UAER, mg/gr, mean (SD)* 29.5 (109.4) 28.4 (88.2) 43.6 (185.4) 24.1 (80.4)
GFR, mil/min/1.73 m2, mean (SD) 75.6 (30.4) 76.29 (32.7)   74.1 (23.9)
Diabetic retinopathy, n (%)** 325 (10.7) 238 (13.4) 52 (8.6) 55 (8.3)
Diabetes therapy, n (%)**     
 Diet 560 (18.4) 408 (23.0) 63 (10.4) 89 (13.5)
 OA 1,063 (34.9) 751 (42.3) 223 (36.9) 89 (13.5)
 OA + Insulin 504 (16.5) 150 (8.5) 80 (13.2) 274 (41.4)
 Insulin 192 (6.3) 110 (6.2) 48 (7.9) 34 (5.1)
 OA combined 722 (23.7) 355 (20.0) 191 (31.6) 176 (26.6)
Antihypertensive treatment, n (%)** 1837 (60.4) 1126 (63.5) 270 (44.6) 440 (66.5)
Dyslipidaemia therapy, n (%)** 1417 (46.6) 929 (52.4) 210 (34.8) 410 (61.9)
  1. BMI body mass index, UAER urinary albumin excretion rate, GFR glomerular filtration rate according to MDRD equation, OA oral antidiabetic drug
  2. *p < 0.05
  3. **p <0.005